About Immunoassay Analyzers
Immunoassay analyzers are used to identify and detect the concentration of specific substances in a sample, usually using an antibody as a reagent. These devices can perform a variety of tests. They are used in clinical laboratories and in hospitals for determining protein, bacterial, or viral toxins, drug concentration, infectious diseases, testing allergy and endocrine hormones, and cardiac markers. The immunology analyzer uses certain chemical groups to label antigens or antibodies. The chemical group is oxidized to form an excited state, and in the process of returning to the ground state, it releases photons of a certain wavelength. The immunoassay analyzer market is poised for steady growth due to rising disease burdens, technological advancements, and a growing emphasis on personalized medicine. By addressing unmet needs and expanding into new markets, this sector can continue to play a vital role in global healthcare.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The immunoassay analyzers market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies’ focus related to the immunoassay analyzers market. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Immunoassay Analyzers market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
F. Hoffmann-La Roche Ltd (Switzerland), Siemens (Germany), Fujirebio (Japan), Agappe Diagnostics Ltd. (India), IDS Immunodiagnostic Systems (United Kingdom), Fapon (China), Thermo Fisher Scientific (United Kingdom), Immunodiagnostic Systems, Merck KGaA (Germany) and Olympus Corporation (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Trinity Biotech (Canada), Axion BioSystems, Inc (United States), Alfa Wassermann, Inc. (United States), Luminex Corporation (United States) and DiaSorin S.p.A. (Italy).
Segmentation Overview
AMA Research has segmented the market of Global Immunoassay Analyzers market by , Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Allergy Testing, AIDS, Infectious Disease Testing and Others) and Region.
On the basis of geography, the market of Immunoassay Analyzers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Category, the sub-segment i.e. Benchtop Analyzers will boost the Immunoassay Analyzers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Product Type, the sub-segment i.e. Immunoprecipitation will boost the Immunoassay Analyzers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Immunoassay Analyzers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growing Shift Towards usage of chemiluminescence immunoassay (CLIA) and Rising awareness of early disease detection through screening programs
Market Growth Drivers:
Increasing demand for advanced diagnostic devices and Rising prevalence of chronic and infectious diseases
Challenges:
Stringent regulatory policies for product approvals and quality standards
Restraints:
The Immunoassay analyzer is highly expensive.
Opportunities:
Technological advancement towards the development of assays with higher sensitivities and Growing demand for personalized medicine
Market Leaders and their expansionary development strategies
In January 2024, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd. announced that they have agreed with a Contract Development and Manufacturing Organization (CDMO) partnership for the Cartridge CLIA system reagents manufacturing project for the immunology equipment Mispa i60 and Mispa i121. Notably, the analyzers and reagents will be sold under Agappe’s brand, making Agappe the first Indian local company with a complete Chemiluminescence Solution comprising locally manufactured reagents.
In August 2023, Fapon launched its most efficient chemiluminescence immunoassay analyzer. The high-speed and fully automated analyzer has an ultra-high throughput of 900 tests per hour and features an integrated and compact design with stable performance. Its features a dual-tubes backup substrate system and automatic disposal of reaction cups to reduce contamination.
Key Target Audience
Manufacturing Companies, Research & Development Institutes, Market Research & Consultancy Firm, Potential Investors, Government & Regulatory Bodies and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.